APOH and breast carcinoma: ApoH or beta2 glycoprotein was recognized immunologically over 30 years ago as being increased in the serum of breast cancer patients [36], but the 3808 Da ApoH fragment that we found to be increased in breast cancer sera has not been reported previously.